Literature DB >> 17043071

Substrate mapping vs. tachycardia mapping using CARTO in patients with coronary artery disease and ventricular tachycardia: impact on outcome of catheter ablation.

Marius Volkmer1, Feifan Ouyang, Florian Deger, Sabine Ernst, Masahiko Goya, Dietmar Bänsch, Katharina Berodt, Karl-Heinz Kuck, Matthias Antz.   

Abstract

AIMS: For ablation of ventricular tachycardia (VT) in patients after myocardial infarction, a three-dimensional mapping system is often used. We report on our overall success rate of VT ablation using CARTO in 47 patients, with a subgroup analysis comparing VT mapping with the results of mapping that had to be performed during sinus rhythm or pacing (substrate mapping). METHODS AND
RESULTS: A CARTO map was performed and VT ablation attempted using two strategies: Patients in the VT-mapping group had incessant VT (four patients) or inducible stable VT (18 patients) such that the circuit of the clinical VT could be reconstructed using CARTO. During VT, the critical area of slow conduction was identified using diastolic potentials and conventional concealed entrainment pacing. In contrast, patients in the substrate-mapping group had initially inducible VT. However, a complete VT map was not possible because of catheter-induced mechanical block (six patients) or because haemodynamics deteriorated during the ongoing VT (19 patients). Therefore, pathological myocardium was identified by fragmented, late- and/or low-amplitude (<1.5 mV) bipolar potentials during sinus rhythm or pacing, and the ablation site was primarily determined by pace mapping inside or at the border of this pathological myocardium. Acute ablation success in all patients with regard to non-inducibility of the clinical VT or any slower VT was 79% after a single ablation procedure, but increased to 95% after a mean of 1.2 ablation procedures. However, chronic success was 75%, when it was defined as freedom from any ventricular tachyarrhythmia (VT or VF) during a follow-up of 25+/-13 months. In the subgroup analysis, patients in the VT-mapping group were not significantly different from patients in the substrate-mapping group with regard to age (65+/-7 vs. 65+/-9 years), ejection fraction (30+/-7 vs. 30+/-8%), VT cycle length (448+/-81 vs. 429+/-82 ms), number of radiofrequency applications (17+/-9 vs. 14+/-6 applications), use of an irrigated tip catheter (23 vs. 32%), and ablation results.
CONCLUSION: When using a CARTO-guided approach for VT ablation in patients with coronary artery disease, the freedom from any ventricular arrhythmia is high (75%), but leaves the patient at a 23% risk of developing fast VT/VF during follow-up. Mapping during sinus rhythm or pacing is as successful as mapping during VT.

Entities:  

Mesh:

Year:  2006        PMID: 17043071     DOI: 10.1093/europace/eul109

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  18 in total

1.  2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias.

Authors:  Edmond M Cronin; Frank M Bogun; Philippe Maury; Petr Peichl; Minglong Chen; Narayanan Namboodiri; Luis Aguinaga; Luiz Roberto Leite; Sana M Al-Khatib; Elad Anter; Antonio Berruezo; David J Callans; Mina K Chung; Phillip Cuculich; Andre d'Avila; Barbara J Deal; Paolo Della Bella; Thomas Deneke; Timm-Michael Dickfeld; Claudio Hadid; Haris M Haqqani; G Neal Kay; Rakesh Latchamsetty; Francis Marchlinski; John M Miller; Akihiko Nogami; Akash R Patel; Rajeev Kumar Pathak; Luis C Saenz Morales; Pasquale Santangeli; John L Sapp; Andrea Sarkozy; Kyoko Soejima; William G Stevenson; Usha B Tedrow; Wendy S Tzou; Niraj Varma; Katja Zeppenfeld
Journal:  J Interv Card Electrophysiol       Date:  2020-10       Impact factor: 1.900

2.  Role of catheter ablation of ventricular tachycardia associated with structural heart disease.

Authors:  Roberto De Ponti
Journal:  World J Cardiol       Date:  2011-11-26

3.  Transseptal versus transaortic approach for radiofrequency ablation in patients with cardioverter-defibrillator and electrical storm.

Authors:  Slawomir Pluta; Radoslaw Lenarczyk; Patrycja Pruszkowska-Skrzep; Oskar Kowalski; Adam Sokal; Beata Sredniawa; Michal Mazurek; Zbigniew Kalarus
Journal:  J Interv Card Electrophysiol       Date:  2010-02-24       Impact factor: 1.900

4.  2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias.

Authors:  Edmond M Cronin; Frank M Bogun; Philippe Maury; Petr Peichl; Minglong Chen; Narayanan Namboodiri; Luis Aguinaga; Luiz Roberto Leite; Sana M Al-Khatib; Elad Anter; Antonio Berruezo; David J Callans; Mina K Chung; Phillip Cuculich; Andre d'Avila; Barbara J Deal; Paolo Della Bella; Thomas Deneke; Timm-Michael Dickfeld; Claudio Hadid; Haris M Haqqani; G Neal Kay; Rakesh Latchamsetty; Francis Marchlinski; John M Miller; Akihiko Nogami; Akash R Patel; Rajeev Kumar Pathak; Luis C Sáenz Morales; Pasquale Santangeli; John L Sapp; Andrea Sarkozy; Kyoko Soejima; William G Stevenson; Usha B Tedrow; Wendy S Tzou; Niraj Varma; Katja Zeppenfeld
Journal:  Europace       Date:  2019-08-01       Impact factor: 5.214

5.  Visualization of local abnormal ventricular activities in scar-related ventricular tachycardia. A novel strategy.

Authors:  Harilaos Bogossian; Gerrit Frommeyer; Bernd Lemke; Markus Zarse
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2015-02-03

6.  Long-term outcomes of catheter ablation of ventricular tachycardia in patients with structural heart disease.

Authors:  Masahiko Goya; Masato Fukunaga; Ken-Ichi Hiroshima; Kentaro Hayashi; Yu Makihara; Michio Nagashima; Yoshimori An; Seiji Ohe; Kennosuke Yamashita; Kenji Ando; Hiroyoshi Yokoi; Masashi Iwabuchi; Kouji Katayama; Tomoaki Ito; Harushi Niu
Journal:  J Arrhythm       Date:  2014-07-03

7.  Prophylactic catheter ablation of ventricular tachycardia before cardioverter-defibrillator implantation in patients with non-ischemic cardiomyopathy: Clinical outcomes after a single endocardial ablation.

Authors:  Atsushi Suzuki; Akihiro Yoshida; Asumi Takei; Koji Fukuzawa; Kunihiko Kiuchi; Kaoru Takami; Mitsuaki Itoh; Kimitake Imamura; Ryudo Fujiwara; Tomoyuki Nakanishi; Soichiro Yamashita; Akinori Matsumoto; Akira Shimane; Katsunori Okajima; Ken-Ichi Hirata
Journal:  J Arrhythm       Date:  2015-02-04

8.  Simultaneous epicardial and endocardial substrate mapping and radiofrequency catheter ablation as first-line treatment for ventricular tachycardia and frequent ICD shocks in chronic chagasic cardiomyopathy.

Authors:  Benhur Davi Henz; Thais A do Nascimento; Cristiano de O Dietrich; Charles Dalegrave; Veruska Hernandes; Cezar E Mesas; Luiz R Leite; Claudio Cirenza; Samuel J Asirvatham; Angelo Amato Vincenzo de Paola
Journal:  J Interv Card Electrophysiol       Date:  2009-09-15       Impact factor: 1.900

9.  Catheter-ablation of ventricular tachycardia in patients with coronary artery disease: influence of the endocardial substrate size on clinical outcome.

Authors:  Matthias Antz; Katarzyna Berodt; Dietmar Bänsch; Sabine Ernst; Kr Julian Chun; Kazuhiro Satomi; Boris Schmidt; Sigrid Boczor; Feifan Ouyang; Karl-Heinz Kuck
Journal:  Clin Res Cardiol       Date:  2007-11-28       Impact factor: 5.460

10.  Mapping for the target sites of ablation in post-infarction ventricular tachycardia--is sinus rhythm sufficient?

Authors:  Narayanan Namboodiri
Journal:  Indian Pacing Electrophysiol J       Date:  2009-11-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.